Laxminarayan Bhat - 18 Dec 2024 SCHEDULE 13D/A Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH)

Filing Manager: Laxminarayan Bhat
Reporting Manager: Bhat Laxminarayan
Security: REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share
Symbol: RVPH
Shares outstanding: 47,032,971 shares
Disclosed Ownership: 3,198,242 shares
Ownership: 6.8%
Form type: SCHEDULE 13D/A
Filing time: 20 Dec 2024, 16:30:22 UTC
Date of event: 18 Dec 2024
Next filing: 01 Jul 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Bhat Laxminarayan	6.8%	3,198,242	2,994,173	204,069	Bhat Laxminarayan	Bhat Laxminarayan	0001818245